Anti-Cancer Drugs


ISSN: 0959-4973        年代:1992
当前卷期:Volume 3  issue 6     [ 查看所有卷期 ]

年代:1992
 
     Volume 3  issue 1   
     Volume 3  issue 2   
     Volume 3  issue 3   
     Volume 3  issue 4   
     Volume 3  issue 5   
     Volume 3  issue 6
1. Pituitary tumorsdiagnosis and treatment
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  555-566

RJM Croughs,  

Preview   |   PDF (955KB)

2. Neurotoxicity of interferon‐α
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  567-570

Ofer Merimsky,   Samario Chaitchik,  

Preview   |   PDF (262KB)

3. The impact of phase I clinical trials on the quality of life of patients with cancer
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  571-576

Teresa Melink,   Gary Clark,   Daniel Von Hoff,  

Preview   |   PDF (365KB)

4. Evaluation of combinations of antineoplastic ether phospholipids and chemotherapeutic drugs
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  577-588

Paola Principe,   Hélène Coulomb,   Colette Broquet,   Pierre Braquet,  

Preview   |   PDF (573KB)

5. Intratunical versus parenteral administration of methotrexate
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  589-592

Ahmed Shafik,  

Preview   |   PDF (230KB)

6. Interaction of epirubicin with other cytotoxics and anti‐emetic drugs
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  593-598

W Zhang,   J Zalcberg,   W Cosolo,  

Preview   |   PDF (276KB)

7. Immunomodulatory activity of two new aza alkyl phospholipid antineoplastic drugs
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  599-608

B Pignol,   S Chaumeron,   H Coulomb,   T Maisonnet,   B Vandamme,   C Broquet,   J Mencia-Huerta,   P Braquet,  

Preview   |   PDF (691KB)

8. Clavine alkaloids and derivatives as mutagens detected in the Ames test
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  609-614

Hansruedi Glatt,   Heinz Pertz,   Reinhard Kasper,   Eckart Eich,  

Preview   |   PDF (383KB)

9. Inhibition of membrane redox activity by rhein and adriamycin in human glioma cells
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  615-622

Maurizio Fanciulli,   Francesco Gentile,   Tiziana Bruno,   Marco Paggi,   Marcello Benassi,   Aristide Floridi,  

Preview   |   PDF (456KB)

10. A possible modulatory influence of melatonin on representative phase I and II drug metabolizing enzymes in 9,10‐dimethyl‐1,2‐benzanthracene induced rat mammary tumorigenesis
  Anti-Cancer Drugs,   Volume  3,   Issue  6,   1992,   Page  623-628

Lalita Kothari,   Asha Subramanian,  

Preview   |   PDF (410KB)

首页 上一页 下一页 尾页 第1页 共24条